OPENING | 5th Krakow Educational Workshop on Congenital Heart Disease
Rector of the Jagiellonian University – Wojciech Nowak
Vice-Rector of the Jagiellonian University for Medical College – Tomasz Grodzicki
Dean of Faculty of Medicine Jagiellonian University – Maciej Małecki
Fifty year of pediatric cardiac surgery in Krakow – Janusz H. Skalski
OPENING LECTURE OUT OF THIS WORLD
Michał Heller, Krakow
Did It start with the Bang?
9.55 a.m. – 10.20 a.m. Thomas Spray, Philadelphia
Valve repair versus the Ross procedure – has anything really changed?
10.20 a.m. – 10.45 a.m. Viktor Hraska, Milwaukee
Valve repair – supplementary strategy for supported Ross.
10.45 a.m. – 11.00 a.m. Zsolt Prodan, Budapest
The Ross experience: what we have learned.
11.30 a.m. – 11.55 a.m. Christopher Mascio, Philadelphia
Heartware ventricular assist devices and the total artificial heart in single and two ventricle circulations.
11.55 a.m. – 12.20 p.m. Michael Hübler, Zurich
Extended application of the Heartware HVAD in children and CHD.
12.20 p.m. – 12:45 p.m. Daniel Zimpfer, Vienna
Mechanical circulatory support in children -Vienna experience.
12:45 p.m. – 1:00 p.m. Tomasz Mroczek, Krakow
Krakow initial experience with HVAD in children.
2:35 p.m. – 2.55 p.m. Shakeel A. Qureshi, London
Closing of challenging atrial septal defects.
2:55 p.m. – 3:15 p.m. Gaetano Thiene, Padova
Single ventricle morphology.
3:15 p.m. – 3:35 p.m. Andrew Glatz, Philadelphia
Fontan takedown in the failing Fontan: surgery versus catheter approaches. Interventionist perspective.
3:35 p.m. – 4:00 p.m. Thomas Spray, Philadelphia
Fontan takedown in the failing Fontan: surgery versus catheter approaches. Surgeon perspective.
4:00 p.m. – 4:20 – Andrew Glatz, Philadelphia
The role of systemic-pulmonary arterial collaterals in single ventricle heart disease: do they matter.
9:00 a.m. – 9:25 a.m. Christian Kreutzer, Buenos Aires
Lymphatic system in treatment of single ventricle CHD.
9:25 a.m. – 9:50 a.m. Viktor Hraska, Milwaukee
The thoracic duct decompression – new strategy for treatment of failing Fontan.
9:50 a.m. – 10:10 a.m. Shakeel A. Qureshi, London
Treating of aortic coarctation.
10:10 a.m. – 10:30 a.m. Andrew Glatz, Philadelphia
Stenting of the ductus arteriosus or surgical BT shunt as initial palliation for infants with ductal-dependent pulmonary blood flow: which is best?
10:30 a.m. – 10:50 a.m. Christopher Mascio, Philadelphia
Cellular replacement and augmentation strategies in hypo plastic left heart syndrome.
11:10 a.m. – 11:35 a.m. Thomas Spray, Philadelphia
Pulmonary valve replacement after Tetralogy of Fallot – How early should we replace the pulmonary valve.
11:35 a.m. – 11:55 a.m. Shakeel A. Qureshi, London
Venus valve uses in native, dilated right ventricular outflow tract.
11:55 a.m. – 12:30 p.m. Tomasz Mroczek, Krakow
The novel bioabsorbable pulmonary valved conduit – initial clinical results.
1:00 p.m. – 1:25 p.m. Gaetano Thiene, Padova
Eisenmenger syndrome in congenital heart defects.
1:25 p.m. – 1:40 p.m. Michael Hübler, Zurich
Aortic root translocation – preferred treatment option in TGA, VSD and LVOTO?
1:40 p.m. – 2:15 Daniel Zimpfer, Vienna
Late biventricular conversions.
2:15 p.m. – 2:30 p.m. Daniel Zimpfer, Vienna
Results of the Vienna pediatric heart transplant program.
2:30 p.m. – 2:45 p.m. Zsolt Prodan, Budapest
Congenital heart transplant: the first 10 years at Kids Heart Budapest.
2:45 p.m. – 3:30 p.m. Roman Przybylski, Zabrze
Cardiac transplantation in “single-ventricle” patients.